Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Omega Diagnostics Group Plc | RVKA | Sep 20, 2024 | 0.03 | 0.00 |
Omega Healthcare Investors, Inc. | WX4 | Sep 20, 2024 | 36.13 | -0.06 |
OMEGA PACIFIC RESOURCES | Q0F | Sep 20, 2024 | 0.12 | +7.14 |
Omer S.p.a | 9WR | Sep 20, 2024 | 4.08 | +0.25 |
Omer-Decugis & Cie | 0VC | Sep 20, 2024 | 4.36 | +0.93 |
Omeros Corporation | 3O8 | Sep 20, 2024 | 3.49 | -2.30 |
Omni Bridgeway Limited | MXG1 | Sep 20, 2024 | 0.55 | +1.85 |
Omnia Holdings Ltd | OHZ | Sep 20, 2024 | 3.14 | +0.64 |
Omnicell, Inc. | OC9 | Sep 20, 2024 | 38.60 | +1.05 |
Omnicom Group Inc. | OCN | Sep 20, 2024 | 91.08 | -2.98 |
OMV AG | OMVI | Sep 20, 2024 | 9.25 | +2.21 |
OMV AG | OMV | Sep 20, 2024 | 36.94 | -1.28 |
ON Semiconductor Corporation | XS4 | Sep 20, 2024 | 62.09 | -3.42 |
On the Beach Group plc | 9BP | Sep 20, 2024 | 1.67 | 0.00 |
Oncimmune Holdings plc | OCY | Sep 20, 2024 | 0.15 | +3.38 |
Oncoarendi Therapeutics SA | 1B1 | Sep 20, 2024 | 3.15 | -2.33 |
ONCODES.PREC.MED. EO-,34 | ZR8 | Sep 20, 2024 | 0.93 | -1.28 |
Onconova Therapeutics, Inc. | 0T2 | Sep 20, 2024 | 0.26 | -0.75 |
Oncopeptides | OND | Sep 20, 2024 | 0.17 | -0.57 |
Oncotherpapy Science Inc | 30O | Sep 20, 2024 | 0.23 | +13.86 |
OncoZenge | 8LY | Sep 20, 2024 | 0.57 | +2.14 |
ONDAS HLDGS INC. DL-,0001 | 1B8 | Sep 20, 2024 | 0.67 | -3.60 |
Onde S.A. | 0XF | Sep 20, 2024 | 2.58 | +6.19 |
Ondine Biomedical Inc | VF5 | Sep 20, 2024 | 0.04 | +19.72 |
ONE Gas, Inc. | OG9 | Sep 20, 2024 | 66.00 | +0.76 |
One Liberty Properties, Inc. | O1A | Sep 20, 2024 | 24.80 | -1.59 |
One Media iP Group Plc | 1M9 | Sep 20, 2024 | 0.03 | 0.00 |
One More Level S.A. | 1OJ | Sep 20, 2024 | 0.35 | -7.50 |
One Stop Systems, Inc. | 5MU | Sep 20, 2024 | 1.84 | -0.54 |
OneApex Limited | CWF | Sep 20, 2024 | 0.08 | +2.55 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.